Point72 Hong Kong LTD Magenta Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $5,622 - $9,820	-734 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.1 - $7.94 $2,208 - $2,874	-362 Reduced 33.03%	734 $6,000
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $7,145 - $9,798	1,096 New	1,096 $7,000
Q3 2018 Nov 14, 2018	SELL	$11.32 - $15.7 $91,669 - $127,138	-8,098 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $109,323 - $117,582	8,098 New	8,098 $109,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.